Careers
Contact Us

Stories tagged hiv vaccine

Where Are We Now and What’s Next?

Where Are We Now and What’s Next?

Mosaico Study Update
HVTN News - January 26, 2023
Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review

Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review

HVTN researchers and ethicists say findings will help guide new approaches to HIV vaccine studies
News Releases - January 18, 2023
New Red Ribbon Registry

New Red Ribbon Registry

Community Compass - July 12, 2022
Trial of Innovative HIV Vaccine Using mRNA Technology Enrolls First Participant

Trial of Innovative HIV Vaccine Using mRNA Technology Enrolls First Participant

Community Compass - July 12, 2022
Increased support needed for a coordinated global HIV and COVID-19 response

Increased support needed for a coordinated global HIV and COVID-19 response

News Releases - March 23, 2022
Trial of innovative HIV vaccine using mRNA technology enrolls first participant

Trial of innovative HIV vaccine using mRNA technology enrolls first participant

News Releases - March 14, 2022
Mosaico Study Update

Mosaico Study Update

Community Compass - December 01, 2021
Experimental Phase 2B HIV Vaccine Regimen Provides Insufficient Protection in Preventing HIV

Experimental Phase 2B HIV Vaccine Regimen Provides Insufficient Protection in Preventing HIV

News Releases - August 31, 2021
Reflections on communicating hope from the ground up in commemoration of World AIDS Day

Reflections on communicating hope from the ground up in commemoration of World AIDS Day

HVTN News - December 01, 2020
Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, March 2020

Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, March 2020

News Releases - March 23, 2020
HVTN remains steadfast in the pursuit of a safe and globally effective preventive HIV vaccine

HVTN remains steadfast in the pursuit of a safe and globally effective preventive HIV vaccine

HVTN News - March 20, 2020
Experimental HIV vaccine regimen ineffective in preventing HIV

Experimental HIV vaccine regimen ineffective in preventing HIV

News Releases - February 03, 2020
HVTN study confirms correlates of risk associated with decrease in HIV transmission

HVTN study confirms correlates of risk associated with decrease in HIV transmission

News Releases - October 31, 2019
HVTN study demonstrates anti-HIV antibody responses within 6 weeks of initial HIV vaccination

HVTN study demonstrates anti-HIV antibody responses within 6 weeks of initial HIV vaccination

News Releases - October 01, 2019
Cross clade vaccine induced immune responses found in South Africa from the RV144/Thai HIV Vaccine Regimen

Cross clade vaccine induced immune responses found in South Africa from the RV144/Thai HIV Vaccine Regimen

News Releases - September 18, 2019
HVTN joins new public-private partnership; expands scientific journey for a safe and effective HIV vaccine

HVTN joins new public-private partnership; expands scientific journey for a safe and effective HIV vaccine

News Releases - July 16, 2019
HVTN's large-scale HIV vaccine efficacy trials fully enrolled

HVTN's large-scale HIV vaccine efficacy trials fully enrolled

News Releases - June 21, 2019
Study participants move HIV vaccine clinical trials forward

Study participants move HIV vaccine clinical trials forward

News Releases - December 20, 2018
Moving toward a much needed effective HIV vaccine

Moving toward a much needed effective HIV vaccine

News Releases - July 24, 2018
Proactive planning: the potential benefits of an HIV vaccination campaign - a modeling study

Proactive planning: the potential benefits of an HIV vaccination campaign - a modeling study

News Releases - July 24, 2018

News on HVTN

Read MORE
Year in Pictures: 2022
Year in Pictures: 2022 A look back at the year through compelling images December 12, 2022
Could a 100-year-old TB vaccine help scientists find a better one?
Could a 100-year-old TB vaccine help scientists find a better one? Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis December 12, 2022
Dr. Larry Corey receives Alexander Fleming Award
Dr. Larry Corey receives Alexander Fleming Award Virologist honored by peers for his lifetime achievements against infectious diseases October 21, 2022
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation NIAID director’s determined spirit recognized with honorary Hutch Award August 10, 2022